
James C. Yeung
Examiner (ID: 15138)
| Most Active Art Unit | 3406 |
| Art Unit(s) | 3401, 3749, 3105, 3743, 3404, 3405, 3406, 2899 |
| Total Applications | 2326 |
| Issued Applications | 2124 |
| Pending Applications | 58 |
| Abandoned Applications | 144 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17293469
[patent_doc_number] => 20210389308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => DETECTING ADAPTIVE IMMUNITY TO CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 17/408096
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/408096 | DETECTING ADAPTIVE IMMUNITY TO CORONAVIRUS | Aug 19, 2021 | Abandoned |
Array
(
[id] => 18613611
[patent_doc_number] => 20230280347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => NOVEL CANCER BIOMARKER IN PANCREATIC CANCER OR MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM
[patent_app_type] => utility
[patent_app_number] => 18/018121
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018121
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018121 | NOVEL CANCER BIOMARKER IN PANCREATIC CANCER OR MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM | Jul 25, 2021 | Pending |
Array
(
[id] => 18629532
[patent_doc_number] => 20230288414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19
[patent_app_type] => utility
[patent_app_number] => 18/017249
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017249
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017249 | Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19 | Jul 21, 2021 | Pending |
Array
(
[id] => 18896498
[patent_doc_number] => 20240011983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHOD FOR DETERMINING WHETHER A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT IS UNDERGOING A PRE-FLARE EVENT
[patent_app_type] => utility
[patent_app_number] => 18/016384
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016384
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016384 | METHOD FOR DETERMINING WHETHER A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT IS UNDERGOING A PRE-FLARE EVENT | Jul 20, 2021 | Pending |
Array
(
[id] => 17572171
[patent_doc_number] => 11320436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Methods, arrays and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/377473
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 30897
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377473 | Methods, arrays and uses thereof | Jul 15, 2021 | Issued |
Array
(
[id] => 18316038
[patent_doc_number] => 11630113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Method for assigning antibody standard and determining minimum detection limit of antibody detection reagent
[patent_app_type] => utility
[patent_app_number] => 17/762088
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4828
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762088 | Method for assigning antibody standard and determining minimum detection limit of antibody detection reagent | Jul 15, 2021 | Issued |
Array
(
[id] => 19327009
[patent_doc_number] => 12044686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Compositions and methods for assaying neutralizing antibodies
[patent_app_type] => utility
[patent_app_number] => 17/376058
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13461
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376058 | Compositions and methods for assaying neutralizing antibodies | Jul 13, 2021 | Issued |
Array
(
[id] => 19702637
[patent_doc_number] => 12196656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Device and methods
[patent_app_type] => utility
[patent_app_number] => 17/371025
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 23
[patent_no_of_words] => 22477
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371025 | Device and methods | Jul 7, 2021 | Issued |
Array
(
[id] => 17260053
[patent_doc_number] => 20210373038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOAI
[patent_app_type] => utility
[patent_app_number] => 17/367049
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367049
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367049 | Compositions and methods for purification and detection of HDL and APOAI | Jul 1, 2021 | Issued |
Array
(
[id] => 19962762
[patent_doc_number] => 12332256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Erythrocyte simulating particle, preparation method therefor, and quality control or calibrator containing same
[patent_app_type] => utility
[patent_app_number] => 17/353532
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 4101
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353532
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353532 | Erythrocyte simulating particle, preparation method therefor, and quality control or calibrator containing same | Jun 20, 2021 | Issued |
Array
(
[id] => 18560861
[patent_doc_number] => 11726101
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Adrenomedullin assays and methods for determining mature adrenomedullin
[patent_app_type] => utility
[patent_app_number] => 17/349134
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 9088
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349134 | Adrenomedullin assays and methods for determining mature adrenomedullin | Jun 15, 2021 | Issued |
Array
(
[id] => 18531134
[patent_doc_number] => 20230236205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHOD AND KIT FOR THE EARLY DETECTION OF SEPSIS
[patent_app_type] => utility
[patent_app_number] => 17/928741
[patent_app_country] => US
[patent_app_date] => 2021-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928741 | METHOD AND KIT FOR THE EARLY DETECTION OF SEPSIS | May 30, 2021 | Pending |
Array
(
[id] => 19580780
[patent_doc_number] => 12146887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection
[patent_app_type] => utility
[patent_app_number] => 17/231209
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 70
[patent_no_of_words] => 18246
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231209 | Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection | Apr 14, 2021 | Issued |
Array
(
[id] => 18377244
[patent_doc_number] => 20230152331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => FULL-LENGTH CILP AS A BIOMARKER FOR CARDIAC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/995266
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995266 | FULL-LENGTH CILP AS A BIOMARKER FOR CARDIAC FIBROSIS | Mar 31, 2021 | Pending |
Array
(
[id] => 17143042
[patent_doc_number] => 20210311055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => System and Method for Disease Surveillance and Disease Severity Monitoring for COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/212360
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212360 | System and Method for Disease Surveillance and Disease Severity Monitoring for COVID-19 | Mar 24, 2021 | Abandoned |
Array
(
[id] => 16993273
[patent_doc_number] => 20210231693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => OXIDATIVE STRESS BIOMARKERS TESTING IN CANINES
[patent_app_type] => utility
[patent_app_number] => 17/207254
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207254 | Oxidative stress biomarkers testing in canines | Mar 18, 2021 | Issued |
Array
(
[id] => 18306485
[patent_doc_number] => 20230110385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => NON-INVASIVE DETECTION OF SALIVARY AUTOANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/905419
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905419
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905419 | NON-INVASIVE DETECTION OF SALIVARY AUTOANTIBODIES | Mar 2, 2021 | Pending |
Array
(
[id] => 17358059
[patent_doc_number] => 20220018855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => RGMa Fragment Based Diagnostic Assay
[patent_app_type] => utility
[patent_app_number] => 17/190135
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190135 | RGMa Fragment Based Diagnostic Assay | Mar 1, 2021 | Abandoned |
Array
(
[id] => 20623473
[patent_doc_number] => 12590978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Method for measuring platelet activation based on soluble CLEC-2 and platelet count
[patent_app_type] => utility
[patent_app_number] => 17/904966
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1242
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904966 | METHOD FOR MEASURING PLATELET ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELET COUNT | Feb 25, 2021 | Issued |
Array
(
[id] => 17991280
[patent_doc_number] => 20220357317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHOD AND KIT FOR DETECTING HUMAN a-DEFENSIN HD5, AND ANTIBODIES USED IN SAID METHOD AND KIT
[patent_app_type] => utility
[patent_app_number] => 17/632995
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632995 | METHOD AND KIT FOR DETECTING HUMAN a-DEFENSIN HD5, AND ANTIBODIES USED IN SAID METHOD AND KIT | Jan 21, 2021 | Pending |